Compound guide · Metabolic & GLP-1
Semaglutide: what it is, its legal status and the evidence
The GLP-1 drug behind Ozempic, Wegovy and Rybelsus, prescribed for type 2 diabetes and weight management.
What the evidence shows
Weight loss rests on the STEP program of randomized, placebo-controlled trials; muscle loss and side effects are the trade-offs to read about.
Read the full review: How Does Semaglutide Work? The Mechanism, Plainly
Legal and FDA status
Approved products exist, so the bulks list is not the question here. The question that replaced it is the copies rule: compounders may prepare a version of an approved drug when it is officially in shortage, and the semaglutide shortage that permitted mass compounding ended in 2025.
Anti-doping status
NOT prohibited. Semaglutide is a GLP-1 receptor agonist in WADA's Monitoring Program, meaning WADA is collecting anonymized usage data — not banning it. Using one for legitimate reasons is not an anti-doping rule violation as of the 2026 List. Monitoring status can change, so check the live List.
Read next: every Semaglutide guide
What the evidence says
- How Does Semaglutide Work? The Mechanism, Plainly
- Is Ozempic a Peptide? Yes — and Why It Matters (2026)
- "Ozempic Face": What Actually Causes It, According to the Research
- Semaglutide Before & After: What the Trial Numbers Show
- Does Semaglutide Cause Hair Loss? What the 2026 Research Actually Found
- Does Semaglutide or Tirzepatide Cause Muscle Loss? The Real Numbers
- Stopping Semaglutide or Tirzepatide: Weight Regain and Maintenance
Dosage and how it's taken
Side effects and safety
How it compares
Cost and buying
Legal and FDA status
Cost and where to get it legally
Semaglutide is prescribed through telehealth providers. We compare their published prices and terms:
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.